<img alt="" src="https://secure.lote1otto.com/219869.png" style="display:none;">
Skip to content

Weekly Updates from the COVID-19 Trial Tracker (June 12)


The Cytel COVID-19 Trial Tracker continues to bring you an up to the minute, real time dashboard about COVID-19 trials around the world. Here are a few updates from this week.

 Currently about 800 trials are recruiting globally and 78 have completed.

Approximately half of the trials currently recruiting are based in Europe, Great Britain or North America. The top therapies still recruiting in this geographic area are hydroxychloroquine, plasma based therapy, Azithromycin, Tocilizumab and mAB.

The United States is leading the pack in numbers of trials for all of these therapies, except for Tocilizumab where Spain is taking the lead.

Approximately 20% of all trials globally that are recruiting currently are based in the United States. The United States has not yet completed a trial although a small number are expected to complete by the beginning of July.

Approximately 60,000 patients will be enrolled onto US trials by July 1, 2020.

To learn more: 

Access Tracker

contact iconSubscribe back to top